Epstein Secrets

nce the Parties' relative likelihood of success in establishing liability and damages against the immediate benefits derived from a settlement. See Prudential, 148 F.3d at 319. The Court weighs these factors against the best and worst possible outcomes for Plaintiffs. In re Cendant Corp. Litig., 264 F.3d

iation of merits when parties "exchanged initial disclosures and arrived at the Settlement after negotiation before a retired federal judge."). 4. Girsh factors four and five: the risks of establishing liability and damages The fourth and fifth Girth factors require the Court to balance the Parties'

ssible recovery and reasonableness in light of the risks the parties would face if the case went to trial." Warfarin Sodium, 391 F.3d at 538 (citing Prudential, 148 F.3d at 322). The Court determines "whether the settlement represents a good value for a weak case or a poor value for a strong case." Id. In

e settlement would likely be insignificant when compared with Defendants' total revenues. This factor does not favor approval of the settlement. 7. Girsh factors eight and nine: the reasonableness of the settlement in light of the best recovery [*54] and all the attendant risks of litigation The fina

ssible recovery and reasonableness in light of the risks the parties would face if the case went to trial." Warfarin Sodium, 391 F.3d at 538 (citing Prudential, 148 F.3d at 322). The Court determines "whether the settlement represents a good value for a weak case or a poor value for a strong case." Id. In

e settlement would likely be insignificant when compared with Defendants' total revenues. This factor does not favor approval of the settlement. 7. Girsh factors eight and nine: the reasonableness of the settlement in light of the best recovery [*54] and all the attendant risks of litigation The fina

nce the Parties' relative likelihood of success in establishing liability and damages against the immediate benefits derived from a settlement. See Prudential, 148 F.3d at 319. The Court weighs these factors against the best and worst possible outcomes for Plaintiffs. In re Cendant Corp. Litig., 264 F.3d

iation of merits when parties "exchanged initial disclosures and arrived at the Settlement after negotiation before a retired federal judge."). 4. Girsh factors four and five: the risks of establishing liability and damages The fourth and fifth Girth factors require the Court to balance the Parties'

ns for attorneys' [125] fees. In re Prudential Ins. Co. Am. Sales Prac. Litig. Agent Actions ("Prudential"), 148 F.3d 283, 323 (3d Cir. 1998). The "Prudential considerations are just that, prudential." In re Baby Products Antitrust Litig. ("Baby Products), 708 F.3d 163, 174 (3d Cir. 2013). Finally, the Th

Page 13 2016 U.S. Dist. LEXIS 97188, * GM Truck Prods., 55 F.3d at 785-86 (citing Girsh, 521 F.2d at 157). In addition to the Girsh factors, the Third Circuit encourages district courts to consider additional factors, such as the proba

ssible recovery and reasonableness in light of the risks the parties would face if the case went to trial." Warfarin Sodium, 391 F.3d at 538 (citing Prudential, 148 F.3d at 322). The Court determines "whether the settlement represents a good value for a weak case or a poor value for a strong case." Id. In

e settlement would likely be insignificant when compared with Defendants' total revenues. This factor does not favor approval of the settlement. 7. Girsh factors eight and nine: the reasonableness of the settlement in light of the best recovery [*54] and all the attendant risks of litigation The fina